Secondary prevention of gastric cancer.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 2095710)

Published in Gut on December 01, 2007

Authors

Massimo Rugge1

Author Affiliations

1: Universitè degli Studi di Padova, Istituto Oncologico del Veneto IOV-IRCCS, Via Aristide Gabelli, 61, 35121, Padova, Italy. massimo.rugge@unipd.it

Articles cited by this

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37

Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13

Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89

The Sydney System: histological division. J Gastroenterol Hepatol (1991) 5.49

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst (2000) 4.51

Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66

Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology (1997) 3.04

Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol (1988) 1.56

The biological model of gastric carcinogenesis. IARC Sci Publ (2004) 1.53

The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology (1999) 1.47

The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37

Staging gastritis: an international proposal. Gastroenterology (2005) 1.29

Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol (2006) 1.13

Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol (1996) 1.10

Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05

Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy (1997) 1.03

Atrophic gastritis: pathology and endoscopy in the reversibility assessment. Gut (2003) 0.98

Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol (2006) 0.98

Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut (2007) 0.97

Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand J Gastroenterol (2005) 0.92

Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol (2004) 0.91

Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig Dis Sci (2006) 0.89

In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol (2003) 0.89

Assessing risks for gastric cancer: new tools for pathologists. World J Gastroenterol (2006) 0.82

Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype. J Clin Pathol (2007) 0.82